IL17A and colitis: Collectively, C. tropicalis MYA-3404 uses nicotinamidase, at least partially, to alter nicotinamide metabolism, and thus, protect mice from experimental colitis by inducing IL-17A expression and promoting epithelial cell proliferation in the colon.